Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events-Reference-Cited by-同舟云学术

Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events

Published:2019-04-09 Issue:7 Volume:66 Page:e27747
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Miller Tamara P.¹²^ORCID,Fisher Brian T.³⁴⁵⁶,Getz Kelly D.⁴⁶⁷,Sack Leah⁷,Razzaghi Hanieh⁷⁸,Seif Alix E.⁵⁷^ORCID,Bagatell Rochelle⁵⁷,Adamson Peter C.⁵⁷^ORCID,Aplenc Richard⁴⁵⁶⁷⁸

Affiliation:

1. Aflac Cancer and Blood Disorders CenterChildren's Healthcare of Atlanta Atlanta Georgia

2. Department of PediatricsEmory University School of Medicine Atlanta Georgia

3. Division of Infectious DiseasesThe Children's Hospital of Philadelphia Philadelphia Pennsylvania

4. Center for Pediatric Clinical EffectivenessThe Children's Hospital of Philadelphia Philadelphia Pennsylvania

5. Department of PediatricsUniversity of Pennsylvania School of Medicine Philadelphia Pennsylvania

6. Center for Clinical Epidemiology and BiostatisticsUniversity of Pennsylvania School of Medicine Philadelphia Pennsylvania

7. Division of OncologyThe Children's Hospital of Philadelphia Philadelphia Pennsylvania

8. Department of Biomedical and Health InformaticsThe Children's Hospital of Philadelphia Philadelphia Pennsylvania

Funder

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27747

Reference31 articles.

1. The evolution and application of toxicity criteria

2. National Cancer Institute Cancer Therapy Evaluation Program: Responsible Adverse Event (AE) Reporting: Finding Appropriate AE Terms [database online].http://ctep.cancer.gov/protocolDevelopment/electronic_applications/CTC.htm. Accessed November 8 2018.

3. Statement of Investigator. Form FDA 1572.Rockville MD:Department of Health and Human Services Food and Drug Administration.

4. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

5. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03

2. Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study;Cancer Management and Research;2024-02

3. Effectiveness and Safety of Apatinib Plus Programmed Cell Death Protein 1 Blockades for Patients with Treatment-refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study;Journal of Cancer Prevention;2023-09-30

4. Scales to graduate oral mucositis: What are the limitations?;Oral Oncology;2023-09

5. High burden of clinically significant adverse events associated with contemporary therapy for pediatric T‐cell acute lymphoblastic leukemia/lymphoma;Pediatric Blood & Cancer;2023-07-13